drugset / Trial / NCT06034041

The Effect of Mediclore as an Anti-adhesion Agent and Safety in Full-endoscopic Spine Surgery: a Preliminary Study

NCT06034041 ↗

Phase 4 Unknown 78 enrolled King Chulalongkorn Memorial Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

The goal of this clinical trial is to compare efficacy and safety of Mediclore as anti-adhesion agent in patient who undergo endoscopic lumbar discectomy. The main question\[s\] it aims to answer are: * efficacy (patient-reported outcomes, epidural fibrosis) * safety (complications) Participants will received Mediclore at surgical site after finish the operation in experimental group and normal saline in control group. Researchers will compare to see if experimental group have better patient-reported outcomes (PROs) after surgery with no different in complications rate.

Timeline

Start
2023-10
Primary completion
2024-03
Completion
2024-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject MEDICLORE Other / unclassified 1.5 ml Other

Indications